文献速递腹部介入MR

肝细胞癌局部区域治疗后疗效评估中的DWI/ADC:要点与陷阱

DWI/ADC in response assessment after local-regional treatment of HCC - Pearls and Pitfalls.
PubMed 文献 · Eur J Radiol · 2025-05-06

本文综述了肝细胞癌患者接受局部区域治疗(如TACE、TARE)后,利用弥散加权成像(DWI)及表观弥散系数(ADC)评估疗效的优势与挑战。文章指出LI-RADS治疗反应算法2024版已将轻度-中度T2高信号和弥散受限纳入评估,DWI在TARE后早期反应评估中尤为重要,但治疗后弥散受限的判读可受炎症、出血或周围实质T2弛豫时间等因素影响。

要点

  • LI-RADS TRA 2024版将轻度-中度T2高信号和弥散受限作为辅助特征纳入评估算法。
  • TARE后早期反应评估时,传统大小和强化标准可能难以适用,DWI尤为重要。
  • 治疗后DWI判读需注意炎症、出血及周围实质T2弛豫时间对弥散受限的影响。

核心结论

  • DWI在局部区域治疗后疗效评估中有优势,但治疗后弥散受限的判读存在挑战,需考虑炎症、出血及周围实质T2弛豫时间等因素。

研究设计与样本

  • 综述文章,总结DWI用于肝细胞癌局部区域治疗后疗效判读的优势与挑战,未报告检索范围与纳入文献数量。

关键影像表现/征象

  • LI-RADS TRA 2024版将轻度-中度T2信号强度和弥散受限作为辅助特征纳入评估算法。
  • TARE后早期反应评估中,使用传统大小和强化标准可能具有挑战性。
  • 治疗后DWI可受炎症改变、出血或周围实质T2弛豫时间等因素影响。

诊断标准与关键数值

  • LI-RADS TRA 2024版纳入的辅助特征包括轻度-中度T2信号强度和弥散受限。

临床应用与阅片要点

  • TARE后早期疗效评估可关注DWI上的弥散受限,但需结合炎症、出血及周围实质T2弛豫时间等因素综合判读。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Many patients with hepatocellular carcinoma (HCC) present with advanced-stage disease or multifocal tumors which make them unsuitable for radical treatment options. In such cases, locoregional therapy (LRT) such as transarterial chemoembolization (TACE), transarterial radioembolization (TARE) can be used as a bridge to liver transplantation or to downstage borderline tumors. However, post treatment response assessment can be very difficult, especially in the case of TARE. The recently updated Liver Imaging Reporting and Data System treatment response algorithm (LI-RADS TRA) 2024 guidelines has included ancillary features of mild-moderate T2 signal intensity and diffusion restriction into the assessment algorithm. Diffusion-weighted imaging (DWI) would be particularly important in post-TARE assessment as early response assessment using traditional size and enhancement criteria can be challenging following TARE. However, the interpretation of restricted diffusion in post-treatment imaging can be challenging as DWI can be affected by various factors such as inflammatory changes, haemorrhage, or T2-relaxation time of the surrounding parenchyma. In this review article, we provide an overview of the advantages and challenges in the use of DWI to interpret treatment response after LRT.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Loy LM, How GY, Low HM, et al. DWI/ADC in response assessment after local-regional treatment of HCC - Pearls and Pitfalls. Eur J Radiol. 2025. PMID: 40347825. doi:10.1016/j.ejrad.2025.112156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。